Author:
Moradpour Farhad,Rezaei Satar,Piroozi Bakhtiar,Moradi Ghobad,Moradi Yousef,Piri Negar,Shokri Azad
Abstract
AbstractWe aim to estimate the prevalence of prediabetes, and diabetes mellitus (DM). We estimated awareness, treatment, plasma glucose control, and associated factors in diabetes, as well as, socioeconomic-related inequality in the prevalence of diabetes and prediabetes. Data for adults aged 35–70 years were obtained from the baseline phase of the Dehgolan prospective cohort study (DehPCS). Diabetes status was determined as fasting plasma glucose (FPG) of ≥ 126 mg/dl and/or taking glucose lowering medication confirmed by a medical practitioner. Prediabetes was considered as 100 ≤ FPG ≤ 125 mg/dl. The relative concentration index (RCI) was used to exhibit socioeconomic inequality in the prevalence of prediabetes and DM. Prevalence of prediabetes and DM, diabetes awareness and treatment, and glycemic control of DM 18.22%, 10.00%, 78.50%, 68.91% and, 28.50%, respectively. Increasing age (p < 0.001), Increasing body mass index (BMI) (p < 0.05), ex-smoker (p < 0.01), family history of diabetes (FHD) (p < 0.001), and comorbidity (p < 0.001) were independent risk factors for DM. Age group of 46–60 (p < 0.05), ex-smoker (p < 0.05), FHD (p < 0.05) were increased chance of awareness. Current smokers (p < 0.05), and higher education increase the chance of glycemic control in DM. Both DM (RCI = − 0.234) and prediabetes (RCI = − 0.122) were concentrated significantly among less-educated participants. DM was concentrated significantly among poor (RCI = − 0.094) people. A significant proportion of DM awareness and treatment can be due to the integration of diabetes into the primary health care system. The high prevalence of prediabetes and diabetes, which is affected by socioeconomic inequality and combined with low levels of glycemic control may place a greater burden on the health system. Therefore, awareness, receiving treatment, and glycemic control in people with diabetes, and the socioeconomic status of people have become increasingly important in the near future.
Funder
Iranian Ministry of Health and Medical Education
Publisher
Springer Science and Business Media LLC
Reference64 articles.
1. Honnudóttir, V. et al. Social inequality in type 2 diabetes mellitus in the Faroe Islands: A cross-sectional study. Scand. J. Public Health 50, 638 (2021).
2. Lin, X. et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: An analysis from 1990 to 2025. Sci. Rep. 10(1), 14790 (2020).
3. ID Federation. IDF Diabetes Atlas, 10th edn. https://diabetesatlas.org/. (Accessed 28 April 2022) (2021).
4. National Institute of Health Researches of Iran. Atlas of STEPwise Approach to Noncommunicable Disease (NCD) Risk Factor Surveillance (STEPs) 2021, 1–631 (Spring, 2022).
5. Javanbakht, M., Mashayekhi, A., Baradaran, H. R., Haghdoost, A. & Afshin, A. Projection of diabetes population size and associated economic burden through 2030 in Iran: Evidence from micro-simulation Markov model and Bayesian meta-analysis. PLoS ONE 10(7), e0132505 (2015).
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Knowledge and Awareness of Type 2 Diabetes Complications in Conflict-Affected Regions: A Cross-Sectional Study in Homs, Syria;Cureus;2024-09-05
2. Prevalence, Characteristics and Risk Factors Analysis of Prediabetes: A Cross-Sectional Study;F1000Research;2024-07-29
3. Relationship between diabetes health literacy, distress, burnout, social support, complications, self-care behaviors, and quality of life among patients with type 2 diabetes: a path analysis study;Diabetology & Metabolic Syndrome;2024-07-05
4. Metabolomics Signature in Prediabetes and Diabetes: Insights From Tandem Mass Spectrometry Analysis;Endocrinology, Diabetes & Metabolism;2024-05
5. Prediabetes, undiagnosed T2D, insulin resistance and metabolic syndrome in Guanajuato, Mexico;Salud Pública de México;2024-04-29